Could plant-based, orally administered insulin revolutionize the treatment of diabetes worldwide by providing a more cost-effective, convenient, and secure option than conventional insulin injections?
Exciting advancements in insulin delivery methods are emerging from the world of dentistry. Groundbreaking research has led to the development of a plant-based, oral insulin, opening a new chapter in diabetes treatment.
Key Points:
- Henry Daniell from the School of Dental Medicine has developed a plant-based, oral insulin delivery method that potentially surpasses current diabetes treatments by reducing hypoglycemia risk.
- The oral insulin, derived from lettuce plants, contains all three peptides found in natural insulin, providing a response similar to naturally secreted insulin.
- Clinical trials on diabetic mice showed effective blood sugar regulation within 15 minutes of ingestion, significantly reducing instances of hypoglycemia compared to traditional insulin injections.
- The plant-based production method could eliminate the need for costly lab equipment and offer a room temperature, shelf-stable product, making it a potential game-changer for global diabetes treatment accessibility.
Additional Points:
- Future research plans involve testing the plant-based insulin on canine and human subjects.
- The study received funding support from the National Institutes of Health, United States, and a grant from the Commonwealth of Pennsylvania, Department of Community and Economic Development.
- It should be noted that Henry Daniell holds patents in this field.
Conclusion:
- The development of a plant-based, oral insulin delivery system demonstrates a promising breakthrough in diabetes treatment. This innovative approach could offer a safer, more effective, and globally accessible alternative to traditional insulin injections.
Endocrinology Further Reading